Access to the PDF text

Archives of cardiovascular diseases
Volume 103, n° 8-9
pages 477-485 (août 2010)
Doi : 10.1016/j.acvd.2010.04.004
Received : 19 January 2010 ;  accepted : 2 April 2010
Gene therapy for heart failure
Thérapie génique pour l’insuffisance cardiaque

Figure 1

Figure 1 : 

Excitation-contraction signaling in cardiomyocytes with emphasis on targets for gene therapy. Interplay between calcium handling (purple) and β-adrenergic (blue) systems is illustrated. AC: adenylyl cyclase; ATP: adenosine triphosphate; β-AR: beta adrenergic receptor; I-1: (protein phosphatase) inhibitor-1; cAMP: cyclic adenosine monophosphate; Gs: stimulatory G protein; Gi: inhibitory G protein; NCX: sarcolemnal sodium/calcium exchanger; PKA: protein kinase A; PLN: phospholamban; PP: protein phosphatase; RyR: ryanodine receptor; SERCA: sarcoplasmic/endoplasmic reticulum calcium ATPase; SR: sarcoplasmic reticulum.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline